Trials / Completed
CompletedNCT00238966
Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil
A One Arm, Open-label Study to Investigate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Recipients Who Received Mycophenolate Mofetil (MMF)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 187 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
This extension study is considered to allow patients being treated with EC-MPS to collect further information on the long-term safety of this drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enteric-Coated Mycophenolate Sodium (EC-MPS) |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2005-04-01
- Completion
- 2005-04-01
- First posted
- 2005-10-14
- Last updated
- 2011-01-31
Source: ClinicalTrials.gov record NCT00238966. Inclusion in this directory is not an endorsement.